| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding | |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | Entrez:930 MIM:107265 HGNC:HGNC:1633 Ensembl:ENSG00000177455 AllianceGenome:HGNC:1633 | |
| Description | CD19 molecule | |||||
| GTO ID | GTC0398 |
| Trial ID | NCT03344705 |
| Disease | Hematologic Cancer |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | IM19CAR-T |
| Generation | 2nd |
| Phase | Phase1 |
| Recruitment status | Unknown |
| Title | Safety and Efficacy Evaluation of IM19 Cells |
| Year | 2017 |
| Country | China |
| Company sponsor | Beijing Immunochina Medical Science & Technology Co., Ltd. |
| Other ID(s) | YMCART201701 |
| Vector information | |||||
|
|||||
| Cohort 1 | |||||||||||||||||||
|
|||||||||||||||||||